Resources with keywords: covid-19
A Year into the COVID Pandemic (Document)
This document provides the questions that should be addressed in order to determine what biosafety mitigation strategies need to be used when handling and processing unfixed human blood during the pandemic. The issues addressed should be included in the IBC protocol narrative. The final determination of handling requirements must be made in consultation with the Biological Safety Division and the Institutional Biosafety Committee (IBC).
“Researchers are beginning trials to study the effects of following an initial dose with a
booster produced by another manufacturer.”
“In the near future, travel may require digital documentation showing that passengers have been vaccinated
or tested for the coronavirus.”
Kalish, H, Undiagnosed SARS-CoV-2 seropositivity during the first 6 months of the COVID-19 pandemic in the United States. Sci Transl Med. 2021:13. DOI: 10.1126/scitranslmed.abh38
Kalish H, et al.
The authors measured antibody prevalence in study participants who had not previously been diagnosed with a SARS-CoV-2 infection during the first wave of the COVID-19 pandemic
Xiling, G., Yin, C., Ling, W. et al.
“we used a sequenced SARS-CoV-2 strain from an infected person in Jiangsu, China, to evaluate the inactivation effect of commonly used disinfection methods on SARS-CoV-2. We tested the effect of chlorine-containing disinfectants, two kinds of QAC named Di-N-decyl dimethyl ammonium bromide (DNB) and Di-N-decyl dimethyl ammonium chloride (DNC), ethanol, and heat on SARS-CoV-2 inactivation, to provide important information on their efficiency on virus inactivation.”
Johns Hopkins Medicine experts say cases of the flu are extremely low nationwide this year, because more people received the flu vaccine, schools and businesses are holding virtual classes or meetings and fewer people have been traveling.
